Back to search

Article

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations

2023-08-11

Abstract excerpt

<h4>Background: </h4> Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed in PDAC; some of which are considered for molecular targeted therapies (MTTs), with potential clinical benefits and im-proved outcomes. However, the applica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94067b8c-1cf7-56b9-a5ce-8e2d57601283
DOI
10.20944/preprints202308.0933.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsDOI 10.20944/preprints202308.0933.v1
Targeted Therapies in Pancreatic Cancer: A New Era of Precision MedicineSemantic proximity
Precision medicine for KRAS wild-type pancreatic adenocarcinomas.Semantic proximity
Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.Semantic proximity
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as BiomarkersSemantic proximity
Moving the Needle on Precision Medicine in Pancreatic CancerSemantic proximity
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.Semantic proximity
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implicationsSemantic proximity
NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancerSemantic proximity
Recent advances in precision medicine for pancreatic ductal adenocarcinomaSemantic proximity
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017.Semantic proximity
Clinical Utility of Comprehensive Genomic Profiling for Advanced Pancreatic Cancer: Insights from Real-World Data AnalysisSemantic proximity
An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.Semantic proximity
Select a neighboring publication to make it the new centre.